Clinical Trial Update: Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab and ipilimumab with short-course radiation for locally advanced rectal cancer; the study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Ipilimumab (Yervoy) (ipilimumab)
• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Advanced Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING